PRMT5 and hepatocellular carcinoma: Akt/N-Ras-based HTVi technology is reported to rapidly induce HCC formation accompanied by fatty change lesions [38] and microenvironment change [39], and PRMT5 is involved in regulating the expression of lipogenic genes [40] and promoting cell proliferation [7].